Navigation Links
LS9 Secures $25 Million in Latest Round of Funding
Date:9/24/2009

LS9, Inc., the Renewable Petroleum Company™, today announced it successfully completed a $25 million round of funding. Participating investors included CTTV Investments LLC, the venture capital arm of Chevron Technology Ventures LLC; Flagship Ventures; Khosla Ventures and Lightspeed Venture Partners.

South San Francisco, CA (PRWEB) September 24, 2009 -- LS9, Inc., the Renewable Petroleum Company™, today announced it successfully completed a $25 million round of funding. Participating investors included CTTV Investments LLC, the venture capital arm of Chevron Technology Ventures LLC; Flagship Ventures; Khosla Ventures and Lightspeed Venture Partners.

In May this year, LS9 announced a strategic partnership with Procter & Gamble to support the joint development and commercialization of LS9 technology to produce key chemicals used within the P&G portfolio of consumer products.

"LS9 is proud to attract recognized leaders in consumer products and transportation fuels," said Bill Haywood, CEO of LS9. "This clearly illustrates the future potential of LS9 in both the sustainable chemicals and renewable transportation fuels sectors."

LS9's revolutionary technology uses a one-step fermentation process to convert renewable plant-based materials into a portfolio of UltraClean™ fuels and high-value, sustainable chemicals. "LS9 represents one of the cleanest and most efficient technologies available in the production of high-value, low-carbon, cost effective fuels, and this funding will accelerate our ability to demonstrate commercial level production," said Stephen del Cardayre, Vice President, Research and Development, LS9.

LS9 is currently producing UltraClean™ Diesel at its pilot facility. UltraClean™ Diesel has achieved U.S. and Brazilian performance standards for on-road use, and achieves an 85% reduct
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Neurocrine Biosciences Secures Committed Equity Financing Facility
2. OpenQ Secures Investment from Leading Mid-Atlantic Venture Firm
3. Cappella Inc. Secures $17.3 Million Series C Investment
4. SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Germany & Austria
5. Sinobiopharma Secures Rights to Seven Key Patents
6. Aerovance Secures $38 Million in Equity Financing
7. VIA Pharmaceuticals Secures Financing Up to $10.0 Million
8. Pearl Therapeutics Secures $8 Million in Debt Financing
9. Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets
10. Sopherion Therapeutics Secures $55 Million in Series C Funding
11. Northwest Biotherapeutics Secures $700,000 Equity Financing

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...wswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI)...inth Circuit Court of Appeals reversed a U.S. Dist...wed to pursue all of its claims against The Lash G...for trial. CTI filed a complaint against The Lash...sultant for CTI,s product TRISENOX, in 2007 seekin...
(Date:11/19/2009)... to charge their cell phones and other personal el...overy made by UC San Diego engineers could lead to...do just this. , In recent research, published i...professor in the UCSD Department of Mechanical and...t Mark Hoefer, have found that artificially introd...
(Date:11/19/2009)...RNewswire/ -- Dr. Mate Hidvegi, inventor of Avemar... release issued on November 17 by Biropharma Kft, ...e and self-serving statements about its U.S. compe...ted from his office in Budapest, Hungary: ,, "...not apply to AveULTRA, www.aveultra.com , is mi...
(Date:11/19/2009)...Newswire-FirstCall/ -- Spherix Incorporated (Nasda...etes therapy, and a provider of technical and regu...otechnology and pharmaceutical companies, today an... Shareholders. ,, At the meeting, shareholders ...he following members to the Board of Directors: ,...
Breaking Biology Technology:Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Nanotube defects equal better energy and storage systems 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4
...Consolidated service revenue of $238.7 million gro...es 47.7%, diluted earnings per share grow 25% ...illion - Net quarterly book-to-burn rati...ational,Corporation (Nasdaq: PRXL ) today announc...ded December 31, 2007., For the three months ende...
...osal capacity and capabilities to facilitate ...of-the-art autoclave technology provides environme...n, - With the addition of the autoclave, one of a...ilities in the country capable of treating all typ... - Opportunity for additional revenue str...
...- Dalton Medicinal Chemistry Partners,the Medicina...es that it,has achieved another targeted milestone...ger Ingelheim (Canada) Ltd., Dalton Medicinal Che...stry expertise to design and synthesize novel comp...ringer Ingelheim (Canada) Ltd. Peter,Pekos, Presid...
Other Biology Technology:PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 2PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 3PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 4PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 5PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 6PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 7PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 8PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 9PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 10Sharps Compliance Corp. Announces Purchase of Medical Waste Disposal Facility and Addition of Autoclave Technology 2Sharps Compliance Corp. Announces Purchase of Medical Waste Disposal Facility and Addition of Autoclave Technology 3Sharps Compliance Corp. Announces Purchase of Medical Waste Disposal Facility and Addition of Autoclave Technology 4
(Date:11/21/2009)... b3c newswire / - KINAXO Biotechnologies GmbH an...ng two new investors in the company, Leifina and C... Jrgen Schumacher has been elected as a new member...olders Axel Ullrich, Hellmut Kirchner, Manfred Fer...s Mountain Partners, BioM, High-Tech Grnderfonds, ...
(Date:11/20/2009)...ovember 2009 issue of the journal GENETICS ( htt...ly of genes (1-aminocyclopropane-1-carboxylate syn...n of ethylene. This gas affects many aspects of pl...ndation for future genetic manipulation that could...d thrive in difficult terrain, increase yields, an...
(Date:11/20/2009)...asma lipoprotein concentrations determined by nucl...hers led by Daniel Chasman at Brigham and Women,s ... the Framingham Heart Study in Framingham, and the...ord, England performed genetic association analysi...ropean ancestry from the Women,s Genome Health Stu...
Breaking Biology News(10 mins):KINAXO Completes Financing Round to Enhance Biomarker Development 2KINAXO Completes Financing Round to Enhance Biomarker Development 3It's a gas: New discovery may lead to heartier, high-yielding plants 2Genetic analysis helps dissect molecular basis of cardiovascular disease 2Exploration by explosion 3A Studying the inner realm of living cells 10689 1Eisai Donates More Than 80 Murals to Hospitals Around the United States 61147 1Eisai Donates More Than 80 Murals to Hospitals Around the United States 61147 2Eisai Donates More Than 80 Murals to Hospitals Around the United States 61147 3Clinical Resourcing Firm ASG Changes Name to Ockham 61144 1
...cialist II, and Linheng Li, Ph.D., Associate Inves...ely, on a new publication that clarifies how norma...er stem cells can cause the formation of tumors. ... initiate intestinal polyposis" was posted to the ...theory that cancer stem cells initiate and drive c...
... active older adults infected with HIV has unprote...researchers. A survey of 260 HIV-positive older ad...e, took Viagra and were in a relationship. , AIDs ...03. According to the Centers for Disease Control a...IV/AIDS cases in the United States by 2015 because...
...stopped in its tracks a form of blood cancer in mi...merase, thereby shortening the ends of chromosomes...t critically short, the cell commits suicide as a ... Ph.D., the Daniel Nathans chair of molecular biol...aring online this month at Cancer Cell, uncovers a...
Other Biology News:Linheng Li Lab documents the development of cancer stem cells 21/3 of sexually active older adults with HIV/AIDs has unprotected sex 2Short chromosomes put cancer cells in forced rest 2
GenomePlex Single Cell Whole Genome Amplification Kit from Sigma-Aldrich
Rabbit Anti-Mouse Ym1 Polyclonal Antibody, Unconjugated from StemCell Technologies, Inc.
Taq DNA Polymerase from ABgene
Pyrex brand narrow mouth graduated erlenmeyer flask, student grade from Sigma-Aldrich
Biology Products: